Drawing for Serial No. 85925734

USPTO serial 85925734

Serial No. 85925734

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BELL, MARLENE D
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 85925734?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michele H. Bowman

MICHELE H. BOWMAN ABBOTT LABORATORIES100 ABBOTT PARK RDABBOTT PARK, IL 60064-6008UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Promoting pharmacogenomics, molecular diagnostics and companion diagnostics goods and services of others; consulting regarding regulatory matters, namely, clinical data and regulatory submission management and strategic counseling related to clinical testing, review and approval of diagnostic tests paired with specific therapies, in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics; retail store and wholesale store services featuring diagnostic test kits; retail store and wholesale store services featuring diagnostic reagents; retail store and wholesale store services featuring diagnostic kits composed of DNA probes, reagents and antibodies; retail store and wholesale store services featuring test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring computer software and hardware in the fields of pharmacogenomics, molecular diagnostics and companion diagnosticsACTIVE—
042Scientific and technological research and development services in the areas of pharmacogenomics, molecular diagnostics and companion diagnostics; development of companion diagnostics; Pharmacogenomics research services, namely, biomarker discovery services; molecular diagnostic research services; companion diagnostics research and development of medical tests for diagnosis and treatment; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposesACTIVE—
044Pharmacogenomics services, namely, medical testing for diagnostic or treatment purposes; molecular diagnostics services, namely, medical testing for diagnostic or treatment purposes; companion diagnostics services, namely, medical testing for diagnostic or treatment purposes and managing patient medical testing, namely, medical diagnostic testing monitoring and reporting services; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 28, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 28, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 31, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 30, 2017EX5GSOU EXTENSION 5 GRANTED—
Jan 23, 2017EXT5SOU EXTENSION 5 FILED—
Jan 23, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2016EX4GSOU EXTENSION 4 GRANTED—
Jul 21, 2016EXT4SOU EXTENSION 4 FILED—
Jul 21, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 2, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 1, 2016EX3GSOU EXTENSION 3 GRANTED—
Jan 21, 2016EXT3SOU EXTENSION 3 FILED—
Jan 21, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2015EX2GSOU EXTENSION 2 GRANTED—
Jul 22, 2015EXT2SOU EXTENSION 2 FILED—
Jul 22, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 12, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 11, 2015EX1GSOU EXTENSION 1 GRANTED—
Mar 10, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 22, 2015EXT1SOU EXTENSION 1 FILED—
Jan 22, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 22, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 28, 2014NPUBNOTICE OF PUBLICATION—
May 27, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 27, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 7, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 21, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 19, 2014ALIEASSIGNED TO LIE—
Mar 28, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Mar 21, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 21, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 21, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 1, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 28, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2013DOCKASSIGNED TO EXAMINER—
May 17, 2013MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 16, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 10, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance